These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25152802)

  • 1. Functional Characterization of Human Stem Cell-Derived Cardiomyocytes.
    Kirsch GE; Obejero-Paz CA; Bruening-Wright A
    Curr Protoc Pharmacol; 2014; 64():11.12.1-26. PubMed ID: 25152802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction.
    Stoelzle S; Haythornthwaite A; Kettenhofen R; Kolossov E; Bohlen H; George M; Brüggemann A; Fertig N
    J Biomol Screen; 2011 Sep; 16(8):910-6. PubMed ID: 21775699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
    Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
    J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological Analysis of hiPSC-Derived Cardiomyocytes Using a Patch-Clamp Technique.
    Yamamoto Y; Hirose S; Wuriyanghai Y; Yoshinaga D; Makiyama T
    Methods Mol Biol; 2021; 2320():121-133. PubMed ID: 34302654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the DSP-H1684R Genetic Variant on Ion Channels Activity in iPSC-Derived Cardiomyocytes.
    Gusev K; Khudiakov A; Zaytseva A; Perepelina K; Makeenok S; Kaznacheyeva E; Kostareva A
    Cell Physiol Biochem; 2020 Jul; 54(4):696-706. PubMed ID: 32706220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes.
    Peng S; Lacerda AE; Kirsch GE; Brown AM; Bruening-Wright A
    J Pharmacol Toxicol Methods; 2010; 61(3):277-86. PubMed ID: 20153443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.
    Coppini R; Ferrantini C; Yao L; Fan P; Del Lungo M; Stillitano F; Sartiani L; Tosi B; Suffredini S; Tesi C; Yacoub M; Olivotto I; Belardinelli L; Poggesi C; Cerbai E; Mugelli A
    Circulation; 2013 Feb; 127(5):575-84. PubMed ID: 23271797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of electrophysiological activity in human-induced pluripotent stem cell-derived cardiomyocytes exposed to dimethyl sulfoxide and ethanol by manual patch clamp and multi-electrode array system.
    Hyun SW; Kim BR; Hyun SA; Seo JW
    J Pharmacol Toxicol Methods; 2017 Sep; 87():93-98. PubMed ID: 28377112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.
    Ma J; Guo L; Fiene SJ; Anson BD; Thomson JA; Kamp TJ; Kolaja KL; Swanson BJ; January CT
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2006-17. PubMed ID: 21890694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.
    Peters MF; Lamore SD; Guo L; Scott CW; Kolaja KL
    Cardiovasc Toxicol; 2015 Apr; 15(2):127-39. PubMed ID: 25134468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the venom of the spider Ornithoctonus hainana on neonatal rat ventricular myocytes cellular and ionic electrophysiology.
    Zhang Y; Liu J; Liu Z; Wang M; Wang J; Lu S; Zhu L; Zeng X; Liang S
    Toxicon; 2014 Sep; 87():104-12. PubMed ID: 24930961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated Dynamic Clamp for Simulation of I
    Becker N; Horváth A; De Boer T; Fabbri A; Grad C; Fertig N; George M; Obergrussberger A
    Curr Protoc Pharmacol; 2020 Mar; 88(1):e70. PubMed ID: 31868992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput drug profiling with voltage- and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes.
    Bedut S; Seminatore-Nole C; Lamamy V; Caignard S; Boutin JA; Nosjean O; Stephan JP; Coge F
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H44-53. PubMed ID: 27199128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P19 embryonal carcinoma cells: a suitable model system for cardiac electrophysiological differentiation at the molecular and functional level.
    van der Heyden MA; van Kempen MJ; Tsuji Y; Rook MB; Jongsma HJ; Opthof T
    Cardiovasc Res; 2003 May; 58(2):410-22. PubMed ID: 12757875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.
    Guo L; Qian JY; Abrams R; Tang HM; Weiser T; Sanders MJ; Kolaja KL
    Cell Physiol Biochem; 2011; 27(5):453-62. PubMed ID: 21691062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.
    Abassi YA; Xi B; Li N; Ouyang W; Seiler A; Watzele M; Kettenhofen R; Bohlen H; Ehlich A; Kolossov E; Wang X; Xu X
    Br J Pharmacol; 2012 Mar; 165(5):1424-41. PubMed ID: 21838757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.